Eric Stoppenhagen

Phototron, Inc. designed and manufactured indoor mini-greenhouses. The company was headquartered in Los Angeles, CA.

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.

Trist Holdings, Inc. does not have significant operations. The company intends to seek a suitable candidate for a business combination with a private company. Previously, it was engaged in acquisition of parcels of land primarily through the real property tax lien foreclosure process. The company was formerly known as Landbank Group, Inc. and changed its name to Trist Holdings, Inc. in December 2007. Trist Holdings, Inc. was incorporated in 1997 and is based in Newport Beach, California

Gold Hill Resources, Inc. operates as a holding company, which engages in mining and mineral exploration. The company was founded by Mark Flanagan and Chaslav Radovich on March 2, 2001 and is headquartered in Pahrump, NV.

Trist Holdings, Inc. does not have significant operations. The company intends to seek a suitable candidate for a business combination with a private company. Previously, it was engaged in acquisition of parcels of land primarily through the real property tax lien foreclosure process. The company was formerly known as Landbank Group, Inc. and changed its name to Trist Holdings, Inc. in December 2007. Trist Holdings, Inc. was incorporated in 1997 and is based in Newport Beach, California

Woozyfly Inc. (Woozyfly), formerly Known as Pet Express Supply, Inc., was engaged in selling pet products through the Internet. It was founded on September 11, 2003 and is headquartered in New York, NY

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.

Trist Holdings, Inc. does not have significant operations. The company intends to seek a suitable candidate for a business combination with a private company. Previously, it was engaged in acquisition of parcels of land primarily through the real property tax lien foreclosure process. The company was formerly known as Landbank Group, Inc. and changed its name to Trist Holdings, Inc. in December 2007. Trist Holdings, Inc. was incorporated in 1997 and is based in Newport Beach, California

Trist Holdings, Inc. does not have significant operations. The company intends to seek a suitable candidate for a business combination with a private company. Previously, it was engaged in acquisition of parcels of land primarily through the real property tax lien foreclosure process. The company was formerly known as Landbank Group, Inc. and changed its name to Trist Holdings, Inc. in December 2007. Trist Holdings, Inc. was incorporated in 1997 and is based in Newport Beach, California

Trist Holdings, Inc. does not have significant operations. The company intends to seek a suitable candidate for a business combination with a private company. Previously, it was engaged in acquisition of parcels of land primarily through the real property tax lien foreclosure process. The company was formerly known as Landbank Group, Inc. and changed its name to Trist Holdings, Inc. in December 2007. Trist Holdings, Inc. was incorporated in 1997 and is based in Newport Beach, California

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.

Gold Hill Resources, Inc. operates as a holding company, which engages in mining and mineral exploration. The company was founded by Mark Flanagan and Chaslav Radovich on March 2, 2001 and is headquartered in Pahrump, NV.

BioImagene, Inc. provides innovative digital pathology solutions for the anatomic pathology laboratory. They are in the business of cancer diagnosis and its goal is to make detection, diagnosis, and therapy selection more accurate, efficient, reliable, and accessible. The firm's solutions allow pathologists to collaborate, learn, educate and provide more reliable and consistent diagnoses. Further, its solutions improve the efficiency of laboratory workflow. BioImagene provides digital pathology solutions. Its systems automate pathology workflows for acquisition, analysis, management, archival, reporting, and sharing of tissue images. The firm offers solutions for pathologists, researchers, and drug developers.

Woozyfly Inc. (Woozyfly), formerly Known as Pet Express Supply, Inc., was engaged in selling pet products through the Internet. It was founded on September 11, 2003 and is headquartered in New York, NY

Woozyfly Inc. (Woozyfly), formerly Known as Pet Express Supply, Inc., was engaged in selling pet products through the Internet. It was founded on September 11, 2003 and is headquartered in New York, NY

Woozyfly Inc. (Woozyfly), formerly Known as Pet Express Supply, Inc., was engaged in selling pet products through the Internet. It was founded on September 11, 2003 and is headquartered in New York, NY

Woozyfly Inc. (Woozyfly), formerly Known as Pet Express Supply, Inc., was engaged in selling pet products through the Internet. It was founded on September 11, 2003 and is headquartered in New York, NY

Woozyfly Inc. (Woozyfly), formerly Known as Pet Express Supply, Inc., was engaged in selling pet products through the Internet. It was founded on September 11, 2003 and is headquartered in New York, NY

Gold Hill Resources, Inc. operates as a holding company, which engages in mining and mineral exploration. The company was founded by Mark Flanagan and Chaslav Radovich on March 2, 2001 and is headquartered in Pahrump, NV.

Gold Hill Resources, Inc. operates as a holding company, which engages in mining and mineral exploration. The company was founded by Mark Flanagan and Chaslav Radovich on March 2, 2001 and is headquartered in Pahrump, NV.

Woozyfly Inc. (Woozyfly), formerly Known as Pet Express Supply, Inc., was engaged in selling pet products through the Internet. It was founded on September 11, 2003 and is headquartered in New York, NY

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.

BioImagene, Inc. provides innovative digital pathology solutions for the anatomic pathology laboratory. They are in the business of cancer diagnosis and its goal is to make detection, diagnosis, and therapy selection more accurate, efficient, reliable, and accessible. The firm's solutions allow pathologists to collaborate, learn, educate and provide more reliable and consistent diagnoses. Further, its solutions improve the efficiency of laboratory workflow. BioImagene provides digital pathology solutions. Its systems automate pathology workflows for acquisition, analysis, management, archival, reporting, and sharing of tissue images. The firm offers solutions for pathologists, researchers, and drug developers.

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.

Woozyfly Inc. (Woozyfly), formerly Known as Pet Express Supply, Inc., was engaged in selling pet products through the Internet. It was founded on September 11, 2003 and is headquartered in New York, NY

BioImagene, Inc. provides innovative digital pathology solutions for the anatomic pathology laboratory. They are in the business of cancer diagnosis and its goal is to make detection, diagnosis, and therapy selection more accurate, efficient, reliable, and accessible. The firm's solutions allow pathologists to collaborate, learn, educate and provide more reliable and consistent diagnoses. Further, its solutions improve the efficiency of laboratory workflow. BioImagene provides digital pathology solutions. Its systems automate pathology workflows for acquisition, analysis, management, archival, reporting, and sharing of tissue images. The firm offers solutions for pathologists, researchers, and drug developers.

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.

Woozyfly Inc. (Woozyfly), formerly Known as Pet Express Supply, Inc., was engaged in selling pet products through the Internet. It was founded on September 11, 2003 and is headquartered in New York, NY

Trist Holdings, Inc. does not have significant operations. The company intends to seek a suitable candidate for a business combination with a private company. Previously, it was engaged in acquisition of parcels of land primarily through the real property tax lien foreclosure process. The company was formerly known as Landbank Group, Inc. and changed its name to Trist Holdings, Inc. in December 2007. Trist Holdings, Inc. was incorporated in 1997 and is based in Newport Beach, California

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.